Milanova Tsveta
SEC CIK 1957180 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AGIO | AGIOS PHARMACEUTICALS, INC. | Chief Commercial Off | 50.1K | — | $741.9K | 20 | 2023-06-28 | 2026-04-02 |
Most active insiders at AGIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Goff Brian | CEO, Dir | — | $1.69M |
| 2 | Gheuens Sarah | Chief Medical Off | — | $1.63M |
| 3 | Jones Cecilia | CFO | — | $468.5K |
| 4 | Milanova Tsveta | Chief Commercial Off | — | $353.3K |
| 5 | Burns James William | CLO | — | $344.4K |
| 6 | Washburn Theodore James Jr. | Principal Accounting Off | — | $216.6K |
| 7 | Viswanadhan Krishnan | Chief Corp Dev, Strategy | — | $185.0K |
| 8 | Scadden David | Dir | — | $25.0K |
| 9 | Owen Adams Catherine | Dir | — | — |
| 10 | Ballal Rahul D. | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-06 16:07 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | M - OptEx | $0.00 | +8,500 | 50.1K | +20% | $0 |
| DT | 2026-04-06 16:07 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | S - Sale+OE | $34.71 | -3,262 | 46.8K | -7% | -$113.2K |
| DM | 2026-03-03 | 2026-03-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | S - Sale+OE | $28.96 | -2,868 | 38.8K | -7% | -$83.1K |
| DM | 2026-03-03 | 2026-03-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | M - OptEx | $0.00 | +9,666 | 40.5K | +31% | $0 |
| D | 2026-01-07 | 2026-01-05 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | S - Sale+OE | $27.02 | -2,872 | 34.8K | -8% | -$77.6K |
| D | 2026-01-07 | 2026-01-05 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | M - OptEx | $0.00 | +8,475 | 37.7K | +29% | $0 |
| D | 2026-01-02 | 2025-12-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | M - OptEx | $0.00 | +6,000 | 32.1K | +23% | $0 |
| D | 2026-01-02 | 2025-12-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | S - Sale+OE | $27.09 | -2,932 | 29.2K | -9% | -$79.4K |
| D | 2025-06-26 | 2025-06-24 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | M - OptEx | $0.00 | +6,000 | 28.9K | +26% | $0 |
| D | 2025-06-26 | 2025-06-24 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | S - Sale+OE | $33.54 | -2,770 | 26.1K | -10% | -$92.9K |
| D | 2025-03-04 | 2025-03-01 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | M - OptEx | $0.00 | +5,667 | 24.6K | +30% | $0 |
| D | 2025-03-04 | 2025-03-03 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | S - Sale+OE | $35.54 | -1,681 | 22.9K | -7% | -$59.7K |
| D | 2025-01-07 | 2025-01-03 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | M - OptEx | $0.00 | +8,476 | 21.7K | +64% | $0 |
| D | 2025-01-07 | 2025-01-06 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | S - Sale+OE | $32.18 | -2,804 | 18.9K | -13% | -$90.2K |
| D | 2024-01-24 | 2024-01-20 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | M - OptEx | $0.00 | +5,448 | 14.9K | +58% | $0 |
| D | 2024-01-24 | 2024-01-24 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | S - Sale+OE | $21.64 | -1,618 | 13.2K | -11% | -$35.0K |
| D | 2024-01-05 | 2024-01-05 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | S - Sale+OE | $22.32 | -2,902 | 9,404 | -24% | -$64.8K |
| D | 2024-01-05 | 2024-01-03 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | M - OptEx | $0.00 | +8,475 | 12.3K | +221% | $0 |
| D | 2023-06-30 | 2023-06-28 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | M - OptEx | $0.00 | +5,449 | 5,449 | New | $0 |
| D | 2023-06-30 | 2023-06-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Chief Commercial Off | S - Sale+OE | $28.36 | -1,618 | 3,831 | -30% | -$45.9K |
Purchase Sale Sale after option exercise All abbreviations